Novo agrees to lower obesity drug prices in the US, Trump announced
Novo Nordisk reached an agreement with the U.S. government to lower prices on diabetes and obesity medication, announced by President Donald Trump at a White House press conference. The agreement aims to enhance access to treatment for individuals over 65 and those with low income. Prices for medications covered by Medicare and Medicaid, which insures […]